5 Pharmaceutical preparations for the treatment and prevention of diseases using protein degradation in the fields of angiology, cardiology, endocrinology, gastroenterology, geriatrics, hematology, hepatology, nephrology, neurology, pulmonology, pneumology, oncology, metabolism, respirology, rheumatology, anesthesiology, urology, dermatology, gynecology, ophthalmology, infectiology, and psychiatry; pharmaceutical preparations, namely, a drug formulation using protein degradation for use in angiology, cardiology, endocrinology, gastroenterology, geriatrics, hematology, hepatology, nephrology, neurology, oncology, metabolism, pulmonology, pneumology, respirology, rheumatology, anesthesiology, urology, dermatology, gynecology, ophthalmology, infectiology, and psychiatry; pharmaceutical preparations for the treatment of infectious, deficiency, hereditary, and physiological diseases; pharmaceutical preparations, namely, targeted therapies that degrade disease driving membrane and extracellular proteins